logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2011 or most recent year available

Part (iv) New hallucinogen inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium00000000000
Bulgaria00000000000
Czech Republic00100000101
Denmark00000000000
Germany0045301013013
Estonia:::::::::::
Ireland100001100202
Greece00000000000
Spain:::::::::::
France00000000000
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary00000100101
Malta:::::::::::
Netherlands00111000303
Austria00010000101
Poland2:1:::::::::
Portugal:::::::::::
Romania04112000808
Slovenia:::::::::::
Slovakia00000000000
Finland00000000000
Sweden100100000101
United Kingdom301240000707
Croatia:51::::::::
Turkey00000000000
Norway:::::::::::
Total0111112721037037
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data. Heroin includes both heroin and so called 'kompot' (heroin gained from the poppy straws).

(3) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-10 part(v), part(vi)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013